AU Patent

AU2015274554B2 — N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide hydrochloride salts

Assigned to GlaxoSmithKline LLC · Expires 2018-02-15 · 8y expired

What this patent protects

The present invention relates to stable novel salt forms of

USPTO Abstract

The present invention relates to stable novel salt forms of

Drugs covered by this patent

Patent Metadata

Patent number
AU2015274554B2
Jurisdiction
AU
Classification
—
Expires
2018-02-15
Drug substance claim
No
Drug product claim
No
Assignee
GlaxoSmithKline LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.